Medical News

Postoperative adjuvant treatment strategy for hepatocellular...

Postoperative adjuvant RT following hepatectomy offers better RFS for HCC patients with MVI than with standard...

03 Jul 2020

Early Serum TARC Reduction Predicts Prognosis in Advanced‐St...

The results indicate that TARC‐2 serum levels above 800 pg/mL suggest the need for a stringent follow‐up in PET‐2‐...

02 Jul 2020

Body mass index increases the lymph node metastasis risk of...

BMI significantly increases the lymph node metastasis risk of breast cancer. Overweight and obese breast cancer...

01 Jul 2020

Bendamustine‐rituximab regimen in untreated indolent margina...

The BR regimen is effective and feasible in MZL patients inducing prolonged disease control with manageable...

30 Jun 2020

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Haematological Malignancies

Haematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. This slide set includes types, risk factors,...

 
Email this page

Key Trials

PROSPER Trial: Enzalutamide Associated with Significantly Prolonged Overall Survival than Placebo in Men with Nonmetastatic, Castration-resistant Prostate Cancer Receiving Androgen-deprivation Therapy

This is the prespecified interim analysis and final analysis of overall survival in the PROSPER trial. PROSPER trial evaluated the efficacy and...

DASSION Trial: 2 -Year Efficacy and Safety of Dasatinib versus Imatinib in Treatment of Newly Diagnosed CML-CP

The present study reports the 2-year results of DASISION Trial that compared safety and efficacy of dasatinib versus imatinib in newly diagnosed...

Salvage Radiotherapy along with Hormone Therapy Improves Outcomes in Prostate Specific Antigen Failure after Radical Prostatectomy

Initial salvage radiation therapy (SRT) prior to salvage hormone therapy (SHT) is beneficial in patients with prostate-specific antigen failure...

Recent Therapeutic Updates on Non-Muscle Invasive Bladder Cancer (NMIBC)

Evaluation of intravesical Bacillus Calmette–Guerin (BCG) treatment on outcomes of patients with T0 after repeat Transurethral resection of bladder...

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9